Proteome Sciences (PRM)

Company name:Proteome Sciences Plc
EPIC:PRMTrading Currency:GBX
Market Sector:ASM7ISIN:GB0003104196
Market Segment:AMSMShare Type:DE
WWW Address:http://www.proteome.co.uk/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 3.25 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 3.00 3.50 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 9.58 294.65 -0.02 -0.44 - - - 4.30 - 2.22

Proteome Sciences Key Figures

(at previous day's close)
Market Cap.9.58m
Shares In Issue294.65m
Prev. Close3.25
PE Ratio- 
Dividend Yield-%
EPS - basic-0.44p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.17p
Return On Equity (ROE)-%
Operating Margin-48.67%
PEG Factor- 
EPS Growth Rate48.24%
Dividends PS Growth Rate-%
Net Debt9.89m
Gross Gearing154.33%
Quick Assets1.61m
Net Working Capital-7.75m
Intangibles / Fixed Assets98.69%
Turnover PS1.16p
Pre-Tax Profit PS-0.56p
Retained Profit PS-0.45p
Cash PS0.33p
Net Cash PS-3.24p
Net Tangible Asset Value PS *-2.73p
Net Asset Value PS-1.30p
Spread0.50 (14.29%) 

Proteome Sciences Balance Sheet

PRM:Liabilities+EQPRM:Assets

Share Price Performance

Sample Period HighLow
1 week3.253.25
4 weeks3.502.80
12 weeks3.762.35
1 year4.302.22

Share Price Chart (5 years)

Proteome Sciences Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3.25--3.250.093.25
4 weeks3.25--2.800.233.07
12 weeks3.020.237.622.350.273.00
26 weeks3.050.206.562.350.223.32
1 year2.450.8032.652.220.233.06
3 years5.35-2.10-39.252.220.353.92
5 years25.25-22.00-87.132.220.318.24

Proteome Sciences Key Management Ratios

Proteome Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.32 
Tobin's Q Ratio (excl. intangibles)3.16 
Dividend Yield-%
Market-to-Book Ratio-2.51 
Price-to-Pre-Tax Profit PS-5.77 
Price-to-Retained Profit PS-7.29 
Price-to-Cash Flow PS-19.00 
Price-to-Sales PS2.81 
Price-to-Net Tangible Asset Value PS-1.19 
Price-to-Cash PS10.00 
Net Working Capital PS-2.63 
Price Pct to Working Capital PS-1.24%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Proteome Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio-9.87%
Debt-to-Equity Ratio-0.09 
Debt-to-Equity Ratio (excl. Intgbl)-0.04 
Debt-to-Equity Market Value0.04 
Net Gearing140.70%
Net Gearing (excl. Intangibles)351.98%
Gross Gearing154.33%
Gross Gearing (excl. Intangibles)386.08%
Gearing Under 1 Year149.45%
Gearing Under 1 Year (excl. Intgbl)373.87%
Assets/Equity-1.84 
Cash/Equity-25.09 
(Liquidity Ratios)
Net Working Capital to Total Assets-110.27%
Current Ratio0.26 
Quick Ratio (Acid Test)0.15 
Liquidity Ratio0.09 
Cash & Equiv/Current Assets34.80%
(Solvency Ratios)
Enterprise Value8.96m
CFO/Sales-0.15 
CFO/Attributable Profit- 
CFO/Assets-0.07 
CFO/Debt-0.05 
Total Debt/Equity Market Value1.13 
Total Debt/Sales3.18 
Total Debt/Pre-Tax Profit-6.54 
Total Debt10.85m
Total Debt/Net Current Assets-1.40%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-22.90%
5 yr Compound Earnings Growth-23.60%
10 yr Compound Earnings Growth-17.52%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)
-0.02120.0007

Proteome Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)-18.11%
Net Profit Margin-38.52%
Assets Turnover0.47 
Return On Equity (ROE)-%
Return On Investment (ROI)46.31%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-38.52%
(Asset Utilisation Multiples)
Shareholders Equity Turnover-1.07 
Fixed Assets Turnover0.78 
Current Assets Turnover1.19 
Net Working Capital Turnover 
Inventory Turnover3.26 
(Other Operating Ratios)
Total Assets-to-Sales2.13 
Debtors-to-Sales25.99%
Debt Collection Period94.86Days

Proteome Sciences Dividends

Sorry No Data Available

Proteome Sciences Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover1.88100.00%2.77100.00%3.38100.00%3.41100.00%m
pre tax profit-3.33-176.73%-2.94-106.09%-2.05-60.74%-1.66-48.67%m
attributable profit-2.72-144.42%-2.28-82.19%-2.50-73.88%-1.31-38.52%m
retained profit-2.72-144.42%-2.28-82.19%-2.50-73.88%-1.31-38.52%m
eps - basic (p)-1.23 -0.96 -0.85 -0.44 
eps - diluted (p)-1.23 -0.96 -0.85 -0.44 
dividends per share- - - - 

Proteome Sciences Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
PRM:Liabilities+EQPRM:AssetsPRM:Liabilities+EQPRM:AssetsPRM:Liabilities+EQPRM:AssetsPRM:Liabilities+EQPRM:Assets
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets0.869.82%0.596.10%0.283.76%0.060.80%m
intangibles intangibles4.2248.32%4.2243.48%4.2256.41%4.2260.03%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.293.33%0.606.19%0.9512.65%1.1516.32%m
debtors debtors1.5617.81%1.4114.49%1.1215.03%0.659.22%m
cash & securities cash & securities1.8120.71%2.8829.73%0.9112.14%0.9613.63%m
TOTAL8.73100%9.70100%7.48100%7.03100%m
LIABILITIES
creditors - short creditors - short9.22105.65%9.3696.52%9.67129.36%10.50149.45%m
creditors - long creditors - long0.667.58%0.535.43%0.364.85%0.344.88%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL9.88113.23%9.89101.95%10.04134.21%10.85154.33%m
EQUITY
ord cap, reserves ord cap, reserves-1.16-13.23%-0.19-1.95%-2.56-34.21%-3.82-54.33%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL-1.16-13.23%-0.19-1.95%-2.56-34.21%-3.82-54.33%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Proteome Sciences Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-2.36-1.99-1.70-0.50m
Pre-Financing CF-2.41-2.03-1.72-0.51m
Retained CF-0.070.88-1.920.03m

Proteome Sciences Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
PRM
Proteome S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191213 16:48:05